Metastatic Prostate Cancer: Androgen Receptor Biology

Joe O’Sullivan, MD, FRCPI, FFRRCSI, FRCR; Johann de Bono, PhD, MB, ChB; Bertrand Tombal, MD, PhD; and Chris Parker, MD, FRCR, MRCP, share insight on androgen receptor biology in aggressive prostate cancer, including how castration resistance develops.